Analysis of CPAF mutants: New functions, new questions (The ins and outs of a chlamydial protease)

Pathogens and Disease

Volumn 71, Issue 3, 2014, Pages 287-291

  Bavoil, Patrik M ^a   Byrne, Gerald I ^b  

^a UNIVERSITY OF MARYLAND DENTAL SCHOOL   (United States)

^b UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

Chlamydia; Pathogenesis; Protease

Indexed keywords

BACTERIAL PROTEIN; CHLAMYDIAL PROTEASE LIKE ACTIVITY FACTOR; SERINE PROTEINASE; UNCLASSIFIED DRUG; PEPTIDE HYDROLASE; VIRULENCE FACTOR;

ARTICLE; BACTERIAL GROWTH; BACTERIUM MUTANT; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN SECRETION; ANIMAL; CHLAMYDIA TRACHOMATIS; ENZYMOLOGY; GENETICS; HOST PATHOGEN INTERACTION; HUMAN; METABOLISM;

ANIMALS; CHLAMYDIA TRACHOMATIS; HOST-PATHOGEN INTERACTIONS; HUMANS; PEPTIDE HYDROLASES; VIRULENCE FACTORS;

EID: 84905678608     PISSN: None     EISSN: 2049632X     Source Type: Journal    
DOI: 10.1111/2049-632X.12194     Document Type: Article

References (46)

1. Bauler LD & Hackstadt T (2014) Expression and targeting of secreted proteins from Chlamydia trachomatis. J Bacteriol 196: 1325-1334.
2. Bednar MM, Jorgensen I, Valdivia RH & McCafferty DG (2011) Chlamydia protease-like activity factor (CPAF): characterization of proteolysis activity in vitro and development of a nanomolar affinity CPAF zymogen-derived inhibitor. Biochemistry 50: 7441-7443.
3. Chen D, Lei L, Flores R, Huang Z, Wu Z, Chai J & Zhong G (2010a) Autoprocessing and self-activation of the secreted protease CPAF in Chlamydia-infected cells. Microb Pathog 49: 164-173.
4. Chen D, Lei L, Lu C, Flores R, Delisa MP, Roberts TC, Romesberg FE & Zhong G (2010b) Secretion of the chlamydial virulence factor CPAF requires the Sec-dependent pathway. Microbiology 156: 3031-3040.
5. Chen AL, Johnson KA, Lee JK, Sutterlin C & Tan M (2012) CPAF: a Chlamydial protease in search of an authentic substrate. PLoS Pathog 8: e1002842.
6. Christian J, Vier J, Paschen SA & Häcker G (2010) Cleavage of the NF-kappaB family protein p65/RelA by the chlamydial protease-like activity factor (CPAF) impairs proinflammatory signaling in cells infected with chlamydiae. J Biol Chem 285: 41320-41327.
7. Christian JG, Heymann J, Paschen SA, Vier J, Schauenburg L, Rupp J, Meyer TF, Hacker G & Heuer D (2011) Targeting of a chlamydial protease impedes intracellular bacterial growth. PLoS Pathog 7: e1002283.
8. Clifton DR, Fields KA, Grieshaber SS, Dooley CA, Fischer ER, Mead DJ, Carabeo RA & Hackstadt T (2004) A chlamydial type III translocated protein is tyrosine-phosphorylated at the site of entry and associated with recruitment of actin. P Natl Acad Sci USA 101: 10166-10171.
9. Conrad AT, Yang Z, Ojcius D & Zhong G (2013) A path forward for the chlamydial virulence factor CPAF. Microbes Infect 15: 1026-1032.
10. Dong F, Pirbhai M, Zhong Y & Zhong G (2004a) Cleavage-dependent activation of a Chlamydia-secreted protease. Mol Microbiol 52: 1487-1494.
11. Dong F, Su H, Huang Y, Zhong Y & Zhong G (2004b) Cleavage of host keratin 8 by a Chlamydia-secreted protease. Infect Immun 72: 3863-3868.
12. Dong F, Zhong Y, Arulanandam B & Zhong G (2005) Production of a proteolytically active protein, chlamydial protease/proteasome-like activity factor, by five different Chlamydia species. Infect Immun 73: 1868-1872.
13. Falkow S (1988) Molecular Koch's postulates applied to microbial pathogenicity. Rev Infect Dis 10(suppl 2): S274-S276.
14. Fan P, Dong F, Huang Y & Zhong G (2002) Chlamydia pneumoniae secretion of a protease-like activity factor for degrading host cell transcription factors required for major histocompatibility complex antigen expression. Infect Immun 70: 345-349.
15. Fields KA, Fischer ER, Mead DJ & Hackstadt T (2005) Analysis of putative Chlamydia trachomatis chaperones Scc2 and Scc3 and their use in the identification of type III secretion substrates. J Bacteriol 187: 6466-6478.
16. Gong S, Lei L, Chang X, Belland R & Zhong G (2011) Chlamydia trachomatis secretion of hypothetical protein CT622 into host cell cytoplasm via a secretion pathway that can be inhibited by the type III secretion system inhibitor compound 1. Microbiology 157: 1134-1144.
17. Häcker G (2014) The chlamydial protease CPAF: important or not, important for what? Microbes Infect 16: 367-370.
18. Heuer D, Brinkmann V, Meyer TF & Szczepek AJ (2003) Expression and translocation of chlamydial protease during acute and persistent infection of the epithelial HEp-2 cells with Chlamydophila (Chlamydia) pneumoniae. Cell Microbiol 5: 315-322.
19. Heuer D, Lipinski Rejman A, Machuy N, Karlas A, Wehrens A, Siedler F, Brinkmann V & Meyer TF (2009) Chlamydia causes fragmentation of the Golgi compartment to ensure reproduction. Nature, 457: 731-735.
20. Hobolt-Pedersen AS, Christiansen G, Timmerman E, Gevaert K & Birkelund S (2009) Identification of Chlamydia trachomatis CT621, a protein delivered through the type III secretion system to the host cell cytoplasm and nucleus. FEMS Immunol Med Microbiol 57: 46-58.
21. Hovis KM, Mojica S, McDermott JE, Pedersen L, Simhi C, Rank RG, Myers GS, Ravel J, Hsia RC & Bavoil PM (2013) Genus-optimized strategy for the identification of chlamydial type III secretion substrates. Pathog Dis 69: 213-222.
22. Hower S, Wolf K & Fields KA (2009) Evidence that CT694 is a novel Chlamydia trachomatis T3S substrate capable of functioning during invasion or early cycle development. Mol Microbiol 72: 1423-1437.
23. Huang ZW, Feng YC, Chen D et al. (2008) Structural basis for activation and inhibition of the secreted Chlamydia protease CPAF. Cell Host Microbe 4: 529-542.
24. Jorgensen I, Bednar MM, Amin V, Davis BK, Ting JP, McCafferty DG & Valdivia RH (2011) The Chlamydia protease CPAF regulates host and bacterial proteins to maintain pathogen vacuole integrity and promote virulence. Cell Host Microbe 10: 21-32.
25. Kawana K, Quayle AJ, Ficarra M et al. (2007) CD1d degradation in Chlamydia trachomatis-infected epithelial cells is the result of both cellular and chlamydial proteasomal activity. J Biol Chem 282: 7368-7375.
26. Kleba B & Stephens RS (2008) Chlamydial effector proteins localized to the host cell cytoplasmic compartment. Infect Immun 76: 4842-4850.
27. Knowlton AE, Brown HM, Richards TS, Andreolas LA, Patel RK & Grieshaber SS (2011) Chlamydia trachomatis infection causes mitotic spindle pole defects independently from its effects on centrosome amplification. Traffic 12: 854-866.
28. Kumar Y & Valdivia RH (2008) Actin and intermediate filaments stabilize the Chlamydia trachomatis vacuole by forming dynamic structural scaffolds. Cell Host Microbe 4: 159-169.
29. Pais SV, Milho C, Almeida F & Mota LJ (2013) Identification of novel type III secretion chaperone-substrate complexes of Chlamydia trachomatis. PLoS One 8: e56292.
30. Paschen SA, Christian JG, Vier J, Schmidt F, Walch A, Ojcius DM & Häcker G (2008) Cytopathicity of Chlamydia is largely reproduced by expression of a single chlamydial protease. J Cell Biol 182: 117-127.
31. Pennini ME, Perrinet S, Dautry-Varsat A & Subtil A. (2010) Histone methylation by NUE, a novel nuclear effector of the intracellular pathogen Chlamydia trachomatis. PLoS Pathog, 6: e1000995.
32. Pirbhai M, Dong F, Zhong Y, Pan KZ & Zhong G (2006) The secreted protease factor CPAF is responsible for degrading pro-apoptotic BH3-only proteins in Chlamydia trachomatis-infected cells. J Biol Chem 281: 31495-31501.
33. Qi M, Lei L, Gong S, Liu Q, DeLisa MP & Zhong G (2011a) Chlamydia trachomatis secretion of an immunodominant hypothetical protein (CT795) into host cell cytoplasm. J Bacteriol 193: 2498-2509.
34. Qi M, Gong S, Lei L, Liu Q & Zhong G (2011b) A Chlamydia trachomatis OmcB C-terminal fragment is released into the host cell cytoplasm and is immunogenic in humans. Infect Immun 79: 2193-2203.
35. Schnell U, Dijk F, Sjollema KA & Giepmans BN (2012) Immunolabeling artifacts and the need for live-cell imaging. Nat Methods 9: 152-158.
36. Shaw AC, Vandahl BB, Larsen MR, Roepstorff P, Gevaert K, Vandekerckhove J, Christiansen G & Birkelund S (2002) Characterization of a secreted Chlamydia protease. Cell Microbiol 4: 411-424.
37. Snavely EA, Kokes M, Dunn JD, Saka HA, Nguyen BD, Bastidas RJ, McCafferty DG & Valdivia RH (2014) Reassessing the role of the secreted protease CPAF in Chlamydia trachomatis infection through genetic approaches. Pathog Dis 71: 336-351.
38. Stone CB, Sugiman-Marangos S, Bulir DC, Clayden RC, Leighton TL, Slootstra JW, Junop MS & Mahony JB (2012) Structural characterization of a novel Chlamydia pneumoniae type III secretion-associated protein, Cpn0803. PLoS One 7: e30220.
39. Subtil A, Blocker A & Dautry-Varsat A (2000) Type III secretion system in Chlamydia species: identified members and candidates. Microbes Infect 2: 367-369.
40. Subtil A, Parsot C & Dautry-Varsat A (2001) Secretion of predicted Inc proteins of Chlamydia pneumoniae by a heterologous type III machinery. Mol Microbiol 39: 792-800.
41. Subtil A, Delevoye C, Balana ME, Tastevin L, Perrinet S & Dautry-Varsat A (2005) A directed screen for chlamydial proteins secreted by a type III mechanism identifies a translocated protein and numerous other new candidates. Mol Microbiol 56: 1636-1647.
42. Sun J & Schoborg RV (2009) The host adherens junction molecule nectin-1 is degraded by chlamydial protease-like activity factor (CPAF) in Chlamydia trachomatis-infected genital epithelial cells. Microbes Infect 11: 12-19.
43. Wang J, Frohlich KM, Buckner L et al. (2011) Altered protein secretion of Chlamydia trachomatis in persistently infected human endocervical epithelial cells. Microbiology 157: 2759-2771.
44. Yu H, Karunakaran KP, Kelly I, Shen C, Jiang X, Foster LJ & Brunham RC (2011) Immunization with live and dead Chlamydia muridarum induces different levels of protective immunity in a murine genital tract model: correlation with MHC class II peptide presentation and multifunctional Th1 cells. J Immunol 186: 3615-3621.
45. Zhong G (2009) Killing me softly: chlamydial use of proteolysis for evading host defenses. Trends Microbiol 17: 467-474.
46. Zhong G, Fan P, Ji H, Dong F & Huang Y (2001) Identification of a chlamydial protease-like activity factor responsible for the degradation of host transcription factors. J Exp Med 193: 935-942.